Current Guidelines for Diagnosis of AMI Chest pain ST change on EKG Cardiac Enzymes

Similar documents
Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

MR Assessment of Myocardial Viability

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

The role of Magnetic Resonance Imaging in the diagnosis of viability & Coronary Artery Disease

The Value of Stress MRI in Evaluation of Myocardial Ischemia

3/27/2014. Introduction.

Imaging and heart failure

Rational use of imaging for viability evaluation

Perfusion, Viability, Edema and Hemorrhage: How it Can (and Should) Change Clinical Practice. Rohan Dharmakumar, Ph.D.

MRI ACS-ben. Tamás Simor MD, PhD, Med Hab. University of Pécs, Heart Institute

Detection and Assessment of MI: Use of Imaging Methods. Robert O. Bonow, M.D.

Old and new insights into viability:perfusion and Perfusion Reserve

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Cardial MRI; Approaching the Level of Gold Standard for Viability Assessment

The use of Cardiac CT and MRI in Clinical Practice

Advanced Imaging MRI and CTA

Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이

Assessment Of Myocardial Viability

Radiologic Assessment of Myocardial Viability

Imaging of Coronary Artery Disease: II

HIGHLIGHT SESSION. Imaging. J. L. Zamorano Gomez (Madrid, ES) Disclosures: Speaker Philips

Echo in CAD: Wall Motion Assessment

IMR in acute STEMI and clinical outcomes

J. Schwitter, MD, FESC Section of Cardiology

Imaging in Ischemic Heart Disease: Role of Cardiac MRI

The best from Euro-Echo Ischemic heart disease. Fausto Rigo,FESC Department of Cardiology Mestre-Venezia Hospital,Italy

Current Indications for Cardiac MRI: What You See is What You Get?

Novel echocardiographic modalities: 3D echo, speckle tracking and strain rate imaging. Potential roles in sports cardiology. Stefano Caselli, MD, PhD

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

Disclosures. GETTING TO THE HEART OF THE MATTER WITH MULTIMODALITY CARDIAC IMAGING Organ Review Meeting 25 September. Overview

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Χ.Τρίκκα Καρδιολογική Κλινική Νοζοκομείο Ερρίκος Νησνάν

FFR in unstable angina and after MI F

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

Debate Should we use FFR? I will say NO.

What the Cardiologist needs to know from Medical Images

Qualitative and Quantitative Assessment of Perfusion

Atypical pain and normal exercise test

Correlation Between Regional Wall Motion Abnormalities via 2-Dimensional Echocardiography, and Coronary Angiographic Findings

Case based learning: CMR in Heart Failure

SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος

ECG in coronary artery disease. By Sura Boonrat Central Chest Institute

CT for Myocardial Characterization of Cardiomyopathy. Byoung Wook Choi, Yonsei University Severance Hospital, Seoul, Korea

CHRONIC CAD DIAGNOSIS

Coronary arteriography in complicated acute myocardial infarction; clinical and angiographic correlates

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

CASE from South Korea

DOWNLOAD PDF MYOCARDIAL CONTRAST TWO DIMENSIONAL ECHOCARDIOGRAPHY (DEVELOPMENTS IN CARDIOVASCULAR MEDICINE)

CNR, G. Monasterio Foundation, Clinical Physiology Institute Pisa

Acute Myocardial Infarction

DELAYED ENHANCEMENT IMAGING IN CHILDREN

Pearls & Pitfalls in nuclear cardiology

All About STEMIs. Presented By: Brittney Urvand, RN, BSN, CCCC. Essentia Health Fargo Cardiovascular Program Manager.

Coronary interventions

Myocardial Strain Imaging in Cardiac Diseases and Cardiomyopathies.

Mechanisms and role of contrast echocardiography

Right ventricular adaptation in endurance athletes. António Freitas. No conflict of interest

I have no financial disclosures

Cardiovascular Imaging Stress Echo

Acute Coronary Syndrome. Sonny Achtchi, DO

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

Test in Subjects with Suspected CAD Anatomic Study is Better

Cardiac MR Cardiac CT

M/39 CC D. => peak CKMB (12 hr later) ng/ml T.chol/TG/HDL/LDL 180/150/48/102 mg/dl #

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Evaluation of Myocardial Viability: What Have We Learned from STICH? Professor of Medicine David Geffen School of Medicine at UCLA. Heart Failure (HF)

63 yo woman with chest pain

Clinical Summary. Live Cases I - IX

Clinical Summary. Live Cases I - IX

Stable Angina: Indication for revascularization and best medical therapy

Recovering Hearts. Saving Lives.

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Chest Pain. Dr Robert Huggett Consultant Cardiologist

Acute chest pain: game changer or waste of resources? CMR one stop shop for function, structure and perfusion

ACUTE CORONARY SYNDROME

Microvascular Disease: How to Diagnose and What s its Treatment

NUCLEAR CARDIOLOGY UPDATE

Newly Diagnosed Heart Failure patient: When to Order an MRI and Why

Subha V. Raman, MD, MSEE, FACC, FAHA

Myocardial Stress Perfusion Imaging using CMR

Cardiac Imaging Tests

Cardiac Risk Factors and Noninvasive Cardiac Diagnosis-ECG, ECHO, et al. Martin C. Burke, DO, FACOI ACOI IM Board Review Course 2018

12 Lead ECGs: Ischemia, Injury & Infarction. Kevin Handke NRP, FP-C, CCP, CMTE STEMI Coordinator Flight Paramedic

Echo is Still Strong in Myocardial Viability Wook-Jin Chung, MD, PhD

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

When is strain assessment mandatory?

Acute Myocarditis Mimicking ST-segment Elevation Myocardial Infarction: Relation Between ECG Changes And Myocardial Damage As Assessed By CMR

VECTORS OF CONTRACTION

Current and Future Imaging Trends in Risk Stratification for CAD

@02-126_Coronary_calcification.ppt. Professor Molecular and Medical Pharmacology

Strain and Strain Rate Imaging How, Why and When?

Validation of CT Perfusion Imaging Against Invasive Angiography and FFR on a 320-MDCT Scanner

Alicia Armour, MA, BS, RDCS

A Qadeer Negahban. Cardiologist Barnsley Hospital United Kingdom

Topic. Updates on Definition of Myocardial Infarction

Imaging congestive heart failure: role of coronary computed tomography angiography (CCTA)

Atherosclerotic Heart Disease: Coronary Vessels, EKG Localization of STEMI and Complications/Derivatives for USMLE Step One

Transcription:

Noninvasive Cardiac Imaging in Myocardial Infarction Sangchol Lee Sungkyunkwan University Samsung Medical Center

Current Guidelines for Diagnosis of AMI Chest pain ST change on EKG Cardiac Enzymes

Do We Need Imaging for AMI Management? Confusing results on EKG Time needed d for enzymes to rise Chest pain - typical? atypical? Measurement of infarct size Post-PCI PCI complications Assessment of residual viable myocardium

Current Noninvasive Imaging Modalities for AMI Diagnosis Echocardiography Radionuclide perfusion scan Cardiac CT Cardiac MRI

Conventional Echocardiography Global LV function Regional wall motion for diagnosis i Complications of MI Myocardial area at risk Myocardial viability - stress echo

1.0 0.8 Survival of Patients with Acute MI Prognosis EF 40% EF >40% E/e 15 1.0 0.8 E/e 15 1 Surviva al 06 0.6 0.4 E/e >15 06 0.6 0.4 E/e >15 0.2 0.2 0.0 0 6 12 18 24 0.0 0 6 12 18 24 Follow-up (months) Follow-up (months) No. at risk 72 52 29 11 4 178 143 84 38 11 Hillis et al: JACC 43(3):360, 2004 CP1141593-3

Prognostic Value of E/E' After Acute MI In DTBT <90 1.0 1.0 E/e' 15 In DTBT 90 E/e' 15 h) al (death Surviva 0.9 0.8 0.7 P=0.06 E/e' >15 h) al (death Surviva 0.9 0.8 0.7 E/e' >15 P<0.0001 0.6 0.6 0.5 0 200 400 600 800 Follow-up (days) 0.5 0 200 400 600 800 Follow-up (days) Park SJ, Ting H, Oh JK Unpublished CP1302151-7

Unconventional Echocardiography Myocardial strain imaging Contrast t echocardiography h

Strain Imaging Strain: Deformation of an object, relative to its original length = L - L 0 L = L0 L 0 L 0 L 0 If 10 cm original length is shortened to 7.5 cm, strain is (-) 25 %. Normal strain is > 20 %. CP1237840-8

2D Speckle Tracking Image Normal Radial strain (SAX) K.Ogawa, T.Hozumi et al. AJC 2006 Transversal strain (A4) Aplio (SSA-770A, Toshiba Japan)

Longitudinal strain: normal case Display 4C 2C Lengthening APLAX Shortening Bull s Eye

Bull s Eye Mapping of Strain +20% Lengthening g -20% Shortening Anteroseptal MI (LAD) Inferolateral MI (LCX) Inferior MI (RCA)

Contrast Echocardiography h Perfusion Defect in the apical segments

Contrast Perfusion Echo for Viability 2 patients with Anterior STEMI and PCI Baseline Follow up

Is there apical thrombus?

CT for Myocardial Imaging Coronary CT angiography Arterial phase myocardial imaging i Myocardial motion interpretation Viability imaging with delayed enhancement

Role of CCT in AMI Evaluation of acute chest pain Myocardial viability

Quantification of Infarct Size

Myocardial Viability

Dual-Phase CT

Dual-Phase CT

CMR: Delayed Enhancement

Two Patients with Inferior STEMI Soon after PCI

Two Patients with Inferior STEMI After PCI and Follow-up

Two Patients with Inferior STEMI Follow-up Echo and Baseline MRI Small DE by Gd Large DE by Gd

Myocardial Function and DHE Transmural extent of infarction and contractility Marholdt, JACC 2003

All Dysfunctional Segments Segments with Severe Hypokinesia, Akinesia, i or Dyskinesia i Segments with Akinesia i or Dyskinesia i ility (% %) ontract oved co Impro 100 80 60 40 20 0 (12 of 12) (128 of 148) (23 (256 of 28) of 329) (56 of (109 86) of 183) (45 of (29 of (9 of 20) 110) 68) (13 of (10 of 124) 103) (4 (1 of (0 of of 54) (0 of 58) 57) 46) 76-100 51-75 26-50 1-25 0 76-100 51-75 26-50 1-25 0 76-100 51-75 26-50 1-25 0 Transmural extent of hyperenhancement (%) R. Kim et al NEJM 2000 CP1302210-5

Prognosis Associated with DHE Chest pain without known OMI Post-STEMI Kwong, Circ 2006 Wu, Heart 2008

Additional Information: Microvascular Obstruction Sakuma, JMRI 2007

Functional Recovery after AMI and MO Nijveldt, JACC 2008

MO and Prognosis Wu, Circulation 1998

AMI with Edema Sakuma, JMRI 2007

T2WI for Edema in MI T2WI-triple IR Myoview Scan

Acute MI with Swelling T2WI

With a Newer Sequence Acute MI Chronic MI Kellman, Magn Reson Med 2007

Peri-Infarct Zone Enhancement (The Grey Zone) 2-3 SD >3 SD Yan AT et al. Circulation 2006;114;32-39.

STEMI? Chest and left arm pain for 1 hr. Increased Troponin

65 year old woman with chest pain

Cine Delayed Enhancement Courtesy of Siemens Med. Systems

Cardiac MRI New Technology Diffusion Tensor Imaging g Myocardial Strain Imaging

Evaluation of Chest Pain Prognosis Viability Imaging CAD Function Infarct size Unstable Hemodynamics and dc Complications CP1210291-8